|
1 Indications And Usage Rasuvo Is A Folate Analog Metabolic Inhibitor Indicated For The: Management Of Patients With Severe, Active Rheumatoid Arthritis (Ra) And Polyarticular Juvenile Idiopathic Arthritis (Pjia), Who Are Intolerant Of Or Had An Inadequate Response To First-Line Therapy ( 1.1 ) Symptomatic Control Of Severe, Recalcitrant, Disabling Psoriasis In Adults Who Are Not Adequately Responsive To Other Forms Of Therapy ( 1.2 ) Limitation Of Use Rasuvo Is Not Indicated For The Treatment Of Neoplastic Diseases ( 1.3 ). 1.1 Rheumatoid Arthritis Including Polyarticular Juvenile Idiopathic Arthritis Rasuvo Is Indicated In The Management Of Selected Adults With Severe, Active Rheumatoid Arthritis (Ra) (Acr Criteria), Or Children With Active Polyarticular Juvenile Idiopathic Arthritis (Pjia), Who Have Had An Insufficient Therapeutic Response To, Or Are Intolerant Of, An Adequate Trial Of First-Line Therapy Including Full Dose Non-Steroidal Anti-Inflammatory Agents (Nsaids). 1.2 Psoriasis Rasuvo Is Indicated In Adults For The Symptomatic Control Of Severe, Recalcitrant, Disabling Psoriasis That Is Not Adequately Responsive To Other Forms Of Therapy, But Only When The Diagnosis Has Been Established, As By Biopsy And/or After Dermatologic Consultation. It Is Important To Ensure That A Psoriasis "flare" Is Not Due To An Undiagnosed Concomitant Disease Affecting Immune Responses. 1.3 Limitation Of Use Rasuvo Is Not Indicated For The Treatment Of Neoplastic Diseases.
|